MGI Pharma starts Irofulven Phase III

MOGN began international Phase III testing

Read the full 66 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE